INDICATION AND IMPORTANT SAFETY INFORMATION
TOBI® Podhaler® (Tobramycin Inhalation Powder) 28 mg per capsule is indicated for the management of cystic fibrosis patients with Pseudomonas aeruginosa.  ...More

PodCare+ is a customizable patient support program for patients that are prescribed TOBI Podhaler

Eligible patients may choose from a variety of support offerings based on their individual needs.

Financial Support

  • With TOBI® Podhaler® Savings Card program enrollment, eligible commercially insured patients may pay as little as $0 for TOBI® Podhaler® prescription. Certain limitations and restrictions apply*

Benefits Investigation

  • Identifies insurance coverage

Support With Prior Authorization

  • Assist with PA requests to facilitate access to medication
  • Follows up to start re-verification process

Dedicated Support Team

  • Personalized support to help patients get started on TOBI Podhaler
  • Coordinate with patient's pharmacy

It’s easy to enroll your patients in PodCare+!

Simply complete the TOBI Podhaler Service Request Form and fax it to PodCare+.
Click Here to enroll your eligible patients in the TOBI Podhaler Savings Card Program.

For questions, call 1-877-999-TOBI (8624).

*This Savings Card can be used to reduce the amount of your out-of-pocket expenses for TOBI® Podhaler® up to a maximum of $14,000 per calendar year while this program remains in effect, with no monthly limit. Mylan Specialty L.P. reserves the right to amend or end this program at any time without notice. This Savings Card can be redeemed only by patients or patient guardians who are 18 years of age or older and who are residents of the United States and its territories. Patients must have commercial insurance. This program is not valid for uninsured patients (but may be used by commercially insured patients without coverage TOBI® Podhaler®) and patients who are covered by any state or federally funded healthcare program, including but not limited to any state pharmaceutical assistance program, Medicare (Part D or otherwise), Medicaid, Medigap, VA or DOD, or TriCare (regardless of whether TOBI® Podhaler® is covered by such government program); not valid if the patient is Medicare eligible and enrolled in an employer-sponsored health plan or prescription benefit program for retirees; and not valid if the patient’s insurance plan is paying the entire cost of this prescription. This program is void outside the US and its territories or where prohibited by law, taxed, or restricted. Absent a change in Massachusetts law, this program will no longer be valid for Massachusetts residents as of January 1, 2020. For full terms and conditions, visit www.activatethecard.com/tobi.

The PodCare+ hotline is available Monday through Friday, 8 AM to 8 PM ET.

A customizable patient support program for patients that are prescribed TOBI Podhaler

Learn more

SET TREATMENT EXPECTATIONS

Inform your patients about what to expect while taking TOBI® Podhaler®

Learn more

ADMINISTRATION INFORMATION

Administration information and helpful tips for patients taking TOBI® Podhaler®

Learn more

Share

To share this website with other health care professionals, please choose your email service provider:

This site is intended for US healthcare professionals. By clicking "continue" you acknowledge that you are a US healthcare professional.

INDICATION AND IMPORTANT SAFETY INFORMATION

INDICATION

TOBI® Podhaler® (Tobramycin Inhalation Powder) 28 mg per capsule is indicated for the management of cystic fibrosis patients with Pseudomonas aeruginosa.

Safety and efficacy have not been demonstrated in patients under the age of 6 years, patients with forced expiratory volume in
1 second
(FEV1) <25% or >80% predicted, or patients colonized with Burkholderia cepacia.